Astana Biomed Group, an authorized Abcam distributor in Central Asia

Anti-Mu Opioid Receptor antibody [UMB3] - BSA and Azide free (ab271900)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [UMB3] to Mu Opioid Receptor - BSA and Azide free
  • Suitable for: WB
  • Reacts with: Mouse, Rat, Human

Overview

  • Product name

    Anti-Mu Opioid Receptor antibody [UMB3] - BSA and Azide free
    See all Mu Opioid Receptor primary antibodies

  • Description

    Rabbit monoclonal [UMB3] to Mu Opioid Receptor - BSA and Azide free

  • Host species

    Rabbit

  • Specificity

    The antibody detects the band of interest in transfected cell lines. When tested in our lab, we were not able to detect any signal from the endogenous protein.

    This antibody can be used in IHC and ICC/IF as demonstrated in several publications, however, it did not pass our internal validation in these applications. Please refer to PMID 20851148, 21957251, 26290245, and other references.

  • Tested Applications & Species

    Application Species
    WB
    Human
    See all applications and species data

  • Immunogen

    Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.

  • Positive control

    • WB: Mu Opioid Receptor transfected HEK-293 lysate.

  • General notes

    ab271900 is the carrier-free version of ab134054. This format is designed for use in antibody labeling, including fluorochromes, metal isotopes, oligonucleotides, enzymes.

     

    Our carrier-free formats are supplied in a buffer free of BSA, sodium azide and glycerol for higher conjugation efficiency.

    Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with

    This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm.

    Maxpar® is a trademark of Fluidigm Canada Inc.

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

Images

  • Western blot - Anti-Mu Opioid Receptor antibody [UMB3] - BSA and Azide free (ab271900)
    Western blot - Anti-Mu Opioid Receptor antibody [UMB3] - BSA and Azide free (ab271900)
    All lanes : Anti-Mu Opioid Receptor antibody [UMB3] - C-terminal (ab134054) at 1/1000 dilution

    Lane 1 : Mu Opioid Receptor transfected HEK-293 (Human epithelial cell line from embryonic kidney) lysate
    Lane 2 : HEK-293T cell lysate

    Lysates/proteins at 10 µg per lane.

    Secondary
    All lanes : HRP labeled goat anti-rabbit at 1/2000 dilution

    Predicted band size: 45 kDa

  • Anti-Mu Opioid Receptor antibody [UMB3] - BSA and Azide free (ab271900)
    Anti-Mu Opioid Receptor antibody [UMB3] - BSA and Azide free (ab271900)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-Mu Opioid Receptor antibody [UMB3] - BSA and Azide free (ab271900)

© 2021 Astana Biomed Group LLP. All rights reserved.